Prognostic significance of p53 histochemistry and DNA histogram parametersin head and neck malignancies

Citation
L. Tamas et al., Prognostic significance of p53 histochemistry and DNA histogram parametersin head and neck malignancies, ANTICANC R, 20(5C), 2000, pp. 4031-4037
Citations number
42
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
20
Issue
5C
Year of publication
2000
Pages
4031 - 4037
Database
ISI
SICI code
0250-7005(200009/10)20:5C<4031:PSOPHA>2.0.ZU;2-K
Abstract
Background: The aim of the study was to determine the role of quantitative pathological parameters in prognosis of head and neck malignancies. Materia ls and Methods: 51 head and neck squamous cell carcinoma patients were exam ined for mutant p53 gene expression (45 out of 51 patients) by immunohistoc hemistry and for cellular DNA-content (44 out of 51 patients) using digital picture analyzer. Statistical analysis was performed using BMDP package. R esults: No correlation with prognosis was found for age, sex, localization, T-classification and therapy Then was significant relationship between N-s tatus and overall survival (p=0.0008). No correlation was found with overal l and disease-free survival for either histologic type or grading. P53: No significant correlation was detected with overall survival. A relationship was found between mutant p53 and metastasis-free time (p=0.06). Ploidy: The re wen no significant differences between aneuploid and euploid tumors for either disease-free or overall survival. Synthetic (S) -phase fraction: A c orrelation was found for both survival rates (p=0.029) and metastasis-free time (p=0.05). Polyploid fraction (PF): correlation was shown for both over all survival (p=0.0128) and metastasis-free time (p=0.0038). Conclusion: Th ere is correlation between p53 overexpression and metastatic potential and there is a significant relationship between SPF and PF value and prognosis (metastasis-free and overall survival) of head and neck cancer.